Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19

Published:2021-05 Issue: Volume:221 Page:107745
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Gilroy Derek W.,De Maeyer Roel P.H.,Tepper Mark,O’Brien Alastair,Uddin Mohib,Chen Judy,Goldstein Daniel R.,Akbar Arne N.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference70 articles.

1. Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2;Alimbetov;Biogerontology,2015

2. Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells;Banerjee;Journal of Virology,2002

3. Targeting potential drivers of COVID-19: Neutrophil extracellular traps;Barnes;Journal of Experimental Medicine,2020

4. Remdesivir for the treatment of Covid-19 — preliminary report;Beigel;New England Journal of Medicine,2020

5. Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection;Börgeling;Journal of Biological Chemistry,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder;Frontiers in Pharmacology;2024-03-14

2. METTL14 contributes to acute lung injury by stabilizing NLRP3 expression in an IGF2BP2-dependent manner;Cell Death & Disease;2024-01-13

3. The influence of propolis plus Hyoscyamus niger L. against COVID‐19: A phase II, multicenter, placebo‐controlled, randomized trial;Phytotherapy Research;2023-11-22

4. Phenotypic and functional alterations of monocyte subsets with aging;Immunity & Ageing;2022-12-13

5. Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects;Life Sciences;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3